Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

732
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
732
Assessment of the Rectum and Anus01:25

Assessment of the Rectum and Anus

1.1K
Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
1.1K
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

726
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
726
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

635
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
635
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

747
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
747
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives01:22

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives

530
Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
530

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early Soluble B-Cell Maturation Antigen (BCMA/TNFRSF17) Kinetics as a Molecular Biomarker of Treatment Response in Multiple Myeloma Patients.

International journal of molecular sciences·2026
Same author

Lymphoid interstitial pneumonia in Sjögren disease: clinical course and comparison with other interstitial lung disease patterns.

Rheumatology (Oxford, England)·2026
Same author

Comparative midterm results of surgical mitral valve replacement and transcatheter mitral valve replacement with the Tendyne System.

JTCVS structural and endovascular·2026
Same author

Characterization of meningeal diverticula in patients with cerebrospinal fluid-venous fistulas.

Journal of neurointerventional surgery·2026
Same author

Effects of γ-Aminobutyric Acid (GABA) Supplementation on Symptoms, Quality of Life, Intestinal Permeability, Systemic Inflammation and Gut Microbiota in Patients with IBS-D: A Randomized, Double Blind, Placebo-Controlled, Crossover Pilot Study.

Nutrients·2026
Same author

Generative AI versus evidence-based resources in clinical decision-making by gastroenterology residents: an AIGO experiment.

Minerva gastroenterology·2026
Same journal

The Drought of Evidence for Water Intake to Manage Constipation Symptoms May Be Ending.

Neurogastroenterology and motility·2026
Same journal

L-Carnitine Improves Visceral Hypersensitivity and Colonic Hyperpermeability in a Rat Model of Irritable Bowel Syndrome.

Neurogastroenterology and motility·2026
Same journal

Letter to the Editor: "Magnesium-Rich Mineral Water Improves Stool Consistency and Bowel Habits in Healthy Subjects: A Randomized Controlled Trial".

Neurogastroenterology and motility·2026
Same journal

Expert Clinical Consensus on Body Surface Gastric Mapping Phenotypes for Gastroduodenal Disorders: 'Auckland Classification' v1.0.

Neurogastroenterology and motility·2026
Same journal

Editorial: Bodily Maps of Emotions in Irritable Bowel Syndrome-Implications for Brain-Gut and Gut-Brain Interventions.

Neurogastroenterology and motility·2026
Same journal

ReFerm® a Fermented Oat Gruel Composition, Improves Colonic Barrier Function and Modulates Tricellulin Expression in Patients With Irritable Bowel Syndrome.

Neurogastroenterology and motility·2026
See all related articles

Related Experiment Video

Updated: Jan 17, 2026

Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation
04:04

Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation

Published on: July 5, 2024

955

Rome Constipation Symptoms Augmented by Painful Defecation Predicts Specific Subtypes of Refractory Constipation.

Christian Lambiase1,2, Massimo Bellini1,2, Francesco Rettura1,2,3

  • 1Gastrointestinal Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.

Neurogastroenterology and Motility
|September 17, 2025
PubMed
Summary
This summary is machine-generated.

Painful defecation complaints, when added to Rome III criteria, significantly improve the identification of functional defecation disorder subtypes in chronic constipation patients. This aids in better patient care and may reduce the need for extensive physiological testing.

Keywords:
chronic constipationconstipationdigital rectal examdyssynergic defecationlevator ani tendernesspainful defecationslow transit constipation

More Related Videos

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
03:50

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease

Published on: August 18, 2023

2.7K
Rectal Organoid Morphology Analysis ROMA: A Diagnostic Assay in Cystic Fibrosis
07:56

Rectal Organoid Morphology Analysis ROMA: A Diagnostic Assay in Cystic Fibrosis

Published on: June 10, 2022

3.2K

Related Experiment Videos

Last Updated: Jan 17, 2026

Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation
04:04

Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation

Published on: July 5, 2024

955
Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
03:50

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease

Published on: August 18, 2023

2.7K
Rectal Organoid Morphology Analysis ROMA: A Diagnostic Assay in Cystic Fibrosis
07:56

Rectal Organoid Morphology Analysis ROMA: A Diagnostic Assay in Cystic Fibrosis

Published on: June 10, 2022

3.2K

Area of Science:

  • Gastroenterology
  • Colorectal Surgery
  • Physiology

Background:

  • Functional defecation disorders (FDD) are a common cause of severe constipation.
  • Diagnosing FDD typically requires physiological tests like anorectal manometry (ARM) and balloon expulsion test (BET).
  • Differentiating FDD subtypes is crucial for effective treatment.

Purpose of the Study:

  • To assess if adding the symptom of painful defecation to the Rome III questionnaire can help differentiate refractory chronic constipation subtypes.
  • To correlate patient-reported symptoms with objective physiological findings.

Main Methods:

  • 198 patients with chronic constipation, unresponsive to initial treatment, were enrolled.
  • Patients underwent digital rectal examination (DRE) for tenderness and reported painful defecation frequency.
  • Physiological testing included DRE, ARM, BET, and in some cases, barium defecography and colonic transit time evaluation.

Main Results:

  • 40.9% of patients reported weekly painful defecation, and 43.3% had DRE-tenderness.
  • 48.5% of patients were diagnosed with FDD, primarily dyssynergic defecation (DD) or inadequate defecatory propulsion (IDP).
  • No specific predictors were identified for IDP.

Conclusions:

  • The symptom of painful defecation is a critical addition to the Rome III criteria for identifying specific subtypes of refractory chronic constipation.
  • This symptom-based approach can enhance diagnostic accuracy and potentially reduce reliance on costly physiological testing.
  • Improved identification of constipation subtypes can lead to more targeted and effective patient care.